原代細胞的全球市場

Primary Cells

出版日期: 2024年08月29日 | 出版商:

Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球原電池市場將達18億美元

全球原電池市場預計 2023 年為 11 億美元，預計到 2030 年將達到 18 億美元，2023-2030 年分析期間複合年成長率為 7.1%。人類原代細胞是本報告分析的細分市場之一，預計複合年成長率為 7.4%，到分析期結束時將達到 14 億美元。在分析期間，動物原代細胞領域的複合年成長率預計為 5.7%。

美國市場預估成長2.982億美元，中國複合年成長率為6.7%

預計 2023 年美國原電池市場規模將達 2.982 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.726億美元，2023年至2030年複合年成長率為6.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 6.6% 和 5.7%。在歐洲，德國預計複合年成長率為 5.8%。

全球原電池市場 - 主要趨勢和促進因素總結

原代細胞：生物醫學研究和藥物開發的重要工具

原代細胞是直接取自活組織並在試管內培養的細胞，保留了原始組織的許多生理特徵和功能。與永生化細胞株係不同，原代細胞的壽命有限，因為它們被設計為無限增殖，並且非常模仿體內細胞的行為。這些細胞是生物醫學研究、毒理學研究和藥物開發的重要工具，用於研究正常和病理細胞功能、篩檢潛在候選藥物和疾病模型。原代細胞來自多種組織，包括血液、皮膚、肝臟和大腦，可以透過培養來創建特定器官和系統的模型。原代細胞提供比細胞株更準確和相關的資料，這使得它們對於尋求了解複雜生物過程和開發有效治療方法的研究人員很有價值。

科技進步如何增強原代細胞及其應用？

技術進步顯著改善了原代細胞的分離、培養和應用，使其可用於廣泛的研究和開發。細胞分離技術的創新，例如螢光激活細胞分選（FACS）和磁激活細胞分選（MACS），提高了獲得具有特定性質的純原代細胞群的能力，從而提高了實驗結果的可靠性和可靠性。先進培養基和補充品的發展延長了試管內原代細胞的壽命，允許更長的實驗和更全面的研究。此外，3D細胞培養技術和器官晶片系統的整合使得能夠使用原代細胞創建更多生理相關模型，從而提供對組織功能和疾病機制的更深入的了解。這些技術進步擴大了原代細胞的應用和益處，使其成為尖端生物醫學研究和藥物發現的重要工具。

原代細胞的主要用途和優點是什麼？

原代細胞用於各種研究和開發應用，並具有許多優點，可提高科學研究的準確性和有效性。在藥物開發中，原代細胞用於篩檢潛在候選藥物的功效和毒性，為藥物在人體內如何發揮作用提供更可靠的資料。在疾病建模中，原代細胞用於創建癌症、神經退化性疾病和循環系統疾病等試管內疾病模型，使研究人員能夠在受控環境中研究疾病機制並測試潛在的治療方法。在個人化醫療中，從個別患者獲得的原代細胞用於開發客製化治療方法並預測患者對特定藥物的反應。使用原代細胞的主要優點包括它們能夠忠實地模擬體內條件，提供比細胞株更準確的資料，並提供對複雜生物過程的洞察。原代細胞透過提供適當且可靠的模型系統，在推進生物醫學研究和開發新治療方法方面發揮重要作用。

推動原代細胞市場成長的因素有哪些？

原代細胞市場的成長受到多種因素的推動。一個關鍵的促進因素是生物醫學研究和藥物開發中對更多生理相關模型的需求不斷增加，因為與細胞株相比，原代細胞可以更準確地代表體內條件。改善原代細胞分離、培養和應用的技術進步也在推動市場成長。對個人化醫療的日益關注以及藥物開發中對患者特異性模型的需求進一步推動了對原代細胞的需求。此外，癌症、免疫學和神經科學等領域研究活動的擴大也促進了原代細胞市場的成長，原代細胞對於研究複雜的生物系統至關重要。商業供應商提供的高品質原代細胞以及先進培養系統的使用不斷增加也推動了市場的擴張。這些因素，加上細胞培養技術的不斷創新，正在推動原代細胞市場的持續成長。

調查企業舉例（共22家）

Allcells LLC
American Type Culture Collection（ATCC）
Axol Bioscience Ltd.
Cell Biologics, Inc.
Lonza Group AG
Merck KgaA
Promocell GmbH
Thermo Fisher Scientific, Inc.
Zenbio, Inc.

The global market for Primary Cells estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Human Primary Cells, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Animal Primary Cells segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$298.2 Million While China is Forecast to Grow at 6.7% CAGR

The Primary Cells market in the U.S. is estimated at US$298.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$272.6 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Primary Cells Market - Key Trends and Drivers Summarized

Primary Cells: Essential Tools for Biomedical Research and Drug Development

Primary cells are cells taken directly from living tissue and cultured in vitro, retaining many of the physiological characteristics and functions of the original tissue. Unlike immortalized cell lines, which are modified to proliferate indefinitely, primary cells have a limited lifespan and closely mimic the behavior of cells in the body. These cells are essential tools in biomedical research, toxicology studies, and drug development, where they are used to study normal and pathological cell functions, screen potential drug candidates, and model diseases. Primary cells are derived from various tissues, including blood, skin, liver, and brain, and can be cultured to create models of specific organs or systems. Their ability to provide more accurate and relevant data than cell lines makes primary cells invaluable for researchers seeking to understand complex biological processes and develop effective therapies.

How Are Technological Advancements Enhancing Primary Cells and Their Applications?

Technological advancements have significantly improved the isolation, culture, and application of primary cells, making them more accessible and useful for a wide range of research and development activities. Innovations in cell isolation techniques, such as fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS), have enhanced the ability to obtain pure populations of primary cells with specific characteristics, improving the reliability and reproducibility of experimental results. The development of advanced culture media and supplements has extended the lifespan of primary cells in vitro, allowing for longer experiments and more comprehensive studies. Additionally, the integration of 3D cell culture technologies and organ-on-a-chip systems has enabled the creation of more physiologically relevant models using primary cells, providing better insights into tissue function and disease mechanisms. These technological improvements have expanded the applications and benefits of primary cells, making them essential tools in cutting-edge biomedical research and drug discovery.

What Are the Key Applications and Benefits of Primary Cells?

Primary cells are used in a variety of research and development applications, offering numerous benefits that enhance the accuracy and relevance of scientific studies. In drug development, primary cells are used to screen potential drug candidates for efficacy and toxicity, providing more reliable data on how a drug will behave in the human body. In disease modeling, primary cells are used to create in vitro models of diseases such as cancer, neurodegenerative disorders, and cardiovascular conditions, allowing researchers to study disease mechanisms and test potential therapies in a controlled environment. In personalized medicine, primary cells derived from individual patients are used to develop customized treatments and predict patient responses to specific drugs. The primary benefits of using primary cells include their ability to closely mimic in vivo conditions, provide more accurate data than cell lines, and offer insights into complex biological processes. By providing a relevant and reliable model system, primary cells play a critical role in advancing biomedical research and developing new therapies.

What Factors Are Driving the Growth in the Primary Cells Market?

The growth in the primary cells market is driven by several factors. The increasing demand for more physiologically relevant models in biomedical research and drug development is a significant driver, as primary cells offer a more accurate representation of in vivo conditions compared to cell lines. Technological advancements that improve the isolation, culture, and application of primary cells are also propelling market growth. The rising focus on personalized medicine and the need for patient-specific models in drug development are further boosting demand for primary cells. Additionally, the expansion of research activities in fields such as cancer, immunology, and neuroscience is contributing to market growth, as primary cells are essential for studying these complex biological systems. The growing availability of high-quality primary cells from commercial suppliers, coupled with the increasing use of advanced culture systems, is also supporting market expansion. These factors, combined with continuous innovation in cell culture technologies, are driving the sustained growth of the primary cells market.

Select Competitors (Total 22 Featured) -

Allcells LLC
American Type Culture Collection (ATCC)
Axol Bioscience Ltd.
Cell Biologics, Inc.
Lonza Group AG
Merck KgaA
Promocell GmbH
Thermo Fisher Scientific, Inc.
Zenbio, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Primary Cells - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Advancements in 3D Cell Culture Technology Propel Growth in Primary Cells Market
- Increasing Investment in Stem Cell Research Expands Addressable Market Opportunity
- CRISPR-Cas9 Technology Adoption Strengthens Business Case for Primary Cells
- Growing Focus on Regenerative Medicine Drives Demand for Animal Primary Cells
- Advancements in Biopharmaceuticals Accelerate Demand for Human Primary Cells
- Expansion of Life Science Research Companies Generates Demand for High-Quality Primary Cells
- Innovations in Cell Preservation Techniques Strengthen Business Case for Primary Cell Usage
- Emergence of Organoid Technology Drives Adoption of Primary Cells in Cancer Research
- Rising Prevalence of Chronic Diseases Expands Addressable Market for Primary Cells
- Increasing Use of Primary Cells in Toxicology Testing Expands Market Opportunities
- Growing Complexity of Drug Discovery and Development Generates Demand for Primary Cells
- Technological Integration with High-Throughput Screening Expands Market Opportunity
- Advancements in Immuno-oncology Research Propel Growth in Primary Cells Market
- Adoption of Next-Generation Sequencing (NGS) Techniques in Primary Cell Research Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Human Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Human Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Animal Primary Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Animal Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Life Science Research Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Life Science Research Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 16: World Primary Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: USA 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 20: USA Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CANADA
- TABLE 23: Canada Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 24: Canada Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: Canada 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 26: Canada Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
JAPAN
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 29: Japan Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: Japan Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: Japan 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 32: Japan Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
CHINA
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 35: China Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: China Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: China 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 38: China Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
EUROPE
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 41: Europe Recent Past, Current & Future Analysis for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 42: Europe Historic Review for Primary Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Europe 16-Year Perspective for Primary Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 44: Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
FRANCE
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 50: France Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: France Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: France 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 53: France Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
GERMANY
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 56: Germany Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: Germany Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: Germany 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 59: Germany Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ITALY
- TABLE 62: Italy Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: Italy Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: Italy 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 65: Italy Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 68: UK Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: UK Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: UK 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 71: UK Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: Rest of Europe Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: Rest of Europe 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Primary Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: Asia-Pacific Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: Asia-Pacific 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 86: Rest of World Recent Past, Current & Future Analysis for Primary Cells by Type - Human Primary Cells and Animal Primary Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of World Historic Review for Primary Cells by Type - Human Primary Cells and Animal Primary Cells Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of World 16-Year Perspective for Primary Cells by Type - Percentage Breakdown of Value Sales for Human Primary Cells and Animal Primary Cells for the Years 2014, 2024 & 2030
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Primary Cells by End-Use - Life Science Research Companies and Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Primary Cells by End-Use - Life Science Research Companies and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Primary Cells by End-Use - Percentage Breakdown of Value Sales for Life Science Research Companies and Research Institutes for the Years 2014, 2024 & 2030